Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion

<div>Atrial fibrillation with fairly regular R-R intervals (ventricular rate 113 bpm) and slower rate while on beta-blocker. The QRS morphology and voltages remain unchanged from prior tracing.</div>

Case Reports in Cardiology

fig4

Figure 4

Figure 4: Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion 

Figure 4 | Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion 